Home › Acute Lymphoblastic Leukemia › Kentucky › Lexington
Acute Lymphoblastic Leukemia clinical trials in Lexington, KY
3 studies for Acute Lymphoblastic Leukemia are looking for participants at sites in and around Lexington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- CommonSpirit Saint Joseph Hospital - Lexington, Lexington
- Saint Joseph Radiation Oncology Resource Center, Lexington
- CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- University of Kentucky/Markey Cancer Center, Lexington
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
RecruitingPhase 3
- Ascentage Investigative Site #1084, Lexington
Acute Lymphoblastic Leukemia trials in other cities
- Houston, TX28 studies
- New York City, NY22 studies
- Seattle, WA22 studies
- Baldwin Park, CA21 studies
- Atlanta, GA20 studies
- Chicago, IL20 studies
- Memphis, TN17 studies
- Philadelphia, PA16 studies
- Washington, DC16 studies
- Los Angeles, CA15 studies
- Boston, MA15 studies
- Mountain View, CA14 studies
Other studies in Lexington
- Non-Small Cell Lung Cancer24 studies
- Lung Cancer17 studies
- Ovarian Cancer15 studies
- Cancer (all types)14 studies
- Breast Cancer13 studies
- Prostate Cancer12 studies
- Obesity12 studies
- Acute Myeloid Leukemia11 studies
- Colorectal Cancer11 studies
- Metastatic Cancer10 studies
- Head and Neck Squamous Cell Carcinoma9 studies
- Heart Failure9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.